SCHEMBL4852869

SCHEMBL4852869

CN(C)CCOc1ccc(/C=C/C(=O)c2ccc(Cl)cc2Cl)c(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 3/20 0.44
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
LSS P48449 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
MAOB P27338 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
CXCL12 P48061 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
MAPT P10636 2/20 0.41
NPC1 O15118 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846138 1.00 KDM4E (0.46) KDM4EALDH1A1THRATHRBBCHE
SCHEMBL4846156 0.92 KDM4E (0.46) KDM4EALDH1A1BCHEACHELSS
SCHEMBL4857406 0.84 BCHE (0.58) BCHEACHEHRH3MAOBCXCL12
SCHEMBL4846784 0.84 BCHE (0.58) BCHEACHEHRH3MAOBCXCL12
SCHEMBL4852227 0.81 KDM4E (0.56) KDM4EALDH1A1BCHEACHEMAOB
SCHEMBL4849629 0.81 KDM4E (0.56) KDM4EALDH1A1BCHEACHEMAOB
SCHEMBL4856209 0.81 MAPT (0.52) KDM4EALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL4846123 0.81 MAPT (0.52) KDM4EALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL4846787 0.80 BCHE (0.61) KDM4EALDH1A1BCHEACHEHRH3
SCHEMBL4849641 0.77 KDM4E (0.56) KDM4EALDH1A1THRATHRBBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed